Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-25T07:40:34.371Z Has data issue: false hasContentIssue false
  • English
  • Français

Axonal Damage in Multiple Sclerosis Patients with High versus Low Expanded Disability Status Scale Score

Published online by Cambridge University Press:  16 February 2016

Steven D. Brass ,
Sridar Narayanan ,
Jack P. Antel ,
Yves Lapierre ,
Louis Collins  and
Douglas L. Arnold
Steven D. Brass
Affiliation:
Montreal Neurological Hospital, Department of Neurology and Neurosurgery, Montreal, Quebec, Canada
Sridar Narayanan
Affiliation:
Montreal Neurological Hospital, Department of Neurology and Neurosurgery, Montreal, Quebec, Canada
Jack P. Antel
Affiliation:
Montreal Neurological Hospital, Department of Neurology and Neurosurgery, Montreal, Quebec, Canada
Yves Lapierre
Affiliation:
Montreal Neurological Hospital, Department of Neurology and Neurosurgery, Montreal, Quebec, Canada
Louis Collins
Affiliation:
Montreal Neurological Hospital, Department of Neurology and Neurosurgery, Montreal, Quebec, Canada
Douglas L. Arnold*
Affiliation:
Montreal Neurological Hospital, Department of Neurology and Neurosurgery, Montreal, Quebec, Canada
*
Montreal Neurological Hospital, Department of Neurology and Neurosurgery, 3801 University Street, Montreal, Quebec H3A2B4, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

The pathophysiological basis for differences in disability in patients with multiple sclerosis is unclear.

Methods:

We used magnetic resonance imaging to examine whether differences in disability in cohorts of multiple sclerosis patients with similar T2-weighted lesion volume and disease duration were associated with a more destructive disease process in the more disabled patients.

Results:

The benign and severely disabled groups had similar brain atrophy metrics and similar decreases of the neuronal marker, N-acetylaspartate, in the normal appearing white matter of the cerebrum on magnetic resonance spectroscopy examination in vivo. The severely disabled cohort had more spinal cord atrophy.

Conclusion:

The dissociation of spinal cord atrophy and cerebral atrophy between these two groups suggests that the difference between the more benign and more disabled groups cannot be explained by a more aggressive pathological process that is affecting the entire neuroaxis in a homogeneous fashion.

Type
Original Article
Information
Canadian Journal of Neurological Sciences , Volume 31 , Issue 2 , May 2004 , pp. 225 - 228
Copyright
Copyright © The Canadian Journal of Neurological 2004

References

1.Thompson, AJ, Kermode, AG, MacManus, DG, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. Br Med J 1990;200:631–634.CrossRefGoogle Scholar
2.Miller, DH, Grossman, RI, Reingold, SC, McFarland, HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3–24.CrossRefGoogle ScholarPubMed
3.Filippi, M, Patty, DW, Kappos, L, et al. Correlations between changes in disability and T2-weighted brain and MRI activity in MS: a follow-up study. Neurology 1995;45:255–260.CrossRefGoogle ScholarPubMed
4.De Stefano, N, Matthews, PM, Antel, JP, et al. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995;38:901–909.CrossRefGoogle ScholarPubMed
5.Iannucci, G, Minicucci, L, Rodegher, M, et al. Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T(1), T(2) and MThistograms. J Neurol Sci 1999; 171:121–129.CrossRefGoogle Scholar
6.Rudick, RA, Fisher, E, Lee, JC (Multiple Sclerosis Collaborative Research Group), et al. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology 1999;53:1698–1704.CrossRefGoogle ScholarPubMed
7.Lucchinetti, C, Bruck, W, Parisi, J, et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47:707–717.3.0.CO;2-Q>CrossRefGoogle ScholarPubMed
8.Fu, L, Matthews, PM, De Stefano, N, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 1998;121:103–113.CrossRefGoogle ScholarPubMed
9.De Stefano, N, Narayanan, S, Francis, GS, et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001;58;65–70.CrossRefGoogle ScholarPubMed
10.Paty, DW, Ebers, GC. Clinical features. In: Paty, DW, Ebers, GC (Eds.) Multiple Sclerosis. Philadelphia: FA Davis 1998: 151–152.Google ScholarPubMed
11.Narayanan, S, De Stefano, N, Francis, S, et al. Disease Duration Influences the Relationship between Brain Axonal Injury, Spinal Cord Atrophy and Disability in Multiple Sclerosis. Proceedings from Annual Meeting of International Socciety for Magnetic Resonance in Medicine. 2000:1297. Abstract.Google Scholar
12.Collins, DL, Narayanan, S, Caramanos, Z, et al. Relation of cerebral atrophy in multiple sclerosis to severity of disease and axonal injury. Neurology 2000;54: A17.Google Scholar
13.Honig, LS, Sheremata, WA. Magnetic resonance imaging of spinal cord lesions in multiple sclerosis. J Neurol Neurosurg Psychiatry 1989;52:459–466.CrossRefGoogle ScholarPubMed
14.Kidd, D, Thorpe, JW, Thompson, AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo II. Findings in multiple sclerosis. Neurology 1993;43:2632–2627.CrossRefGoogle ScholarPubMed